Tech Company Financing Transactions

Pantheon Funding Round

Pantheon closed a $21.5 million Series B financing round on 5/15/2014. Investors included Scale Venture Partners, First Round Capital and Foundry Group.

Transaction Overview

Company Name
Announced On
5/15/2014
Transaction Type
Venture Equity
Amount
$21,500,000
Round
Series B
Investors

Scale Venture Partners (Lead Investor) (Rory O'Driscoll)

First Round Capital

Foundry Group (Ryan McIntyre)

OpenView Venture Partners (Dev Ittycheria)

Proceeds Purpose
Building on its growth and momentum, Pantheon will use the financing to continue to innovate its website platform, scale its platform internationally, and double down on its go-to-market expansion strategy.

Company Information

Company Status
Private & Independent
Industry
Software
Mailing Address
717 California St.
San Francisco, CA 94108
USA
Email Address
Overview
Pantheon is a website operations platform for Drupal and WordPress, running more than 200,000 sites in the cloud and serving over 10 billion pageviews a month. Pantheon's multitenant, container-based platform enables organizations to manage all of their websites from a single dashboard.
Profile
Pantheon LinkedIn Company Profile
Social Media
Pantheon Company Twitter Account
Company News
Pantheon News
Facebook
Pantheon on Facebook
YouTube
Pantheon on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Zack Rosen
  Zack Rosen LinkedIn Profile  Zack Rosen Twitter Account  Zack Rosen News  Zack Rosen on Facebook
Chief Financial Officer
Mark Khavkin
  Mark Khavkin LinkedIn Profile  Mark Khavkin Twitter Account  Mark Khavkin News  Mark Khavkin on Facebook
Chief Marketing Officer
Christy Marble
  Christy Marble LinkedIn Profile  Christy Marble Twitter Account  Christy Marble News  Christy Marble on Facebook
Chief Technical Officer
David Strauss
  David Strauss LinkedIn Profile  David Strauss Twitter Account  David Strauss News  David Strauss on Facebook
Co-Founder
Matthew Cheney
  Matthew Cheney LinkedIn Profile  Matthew Cheney Twitter Account  Matthew Cheney News  Matthew Cheney on Facebook
Controller
Kimberly Kummet
  Kimberly Kummet LinkedIn Profile  Kimberly Kummet Twitter Account  Kimberly Kummet News  Kimberly Kummet on Facebook
Vice President
Matthew Cornett
  Matthew Cornett LinkedIn Profile  Matthew Cornett Twitter Account  Matthew Cornett News  Matthew Cornett on Facebook
Vice President
Mika Kasumov
  Mika Kasumov LinkedIn Profile  Mika Kasumov Twitter Account  Mika Kasumov News  Mika Kasumov on Facebook
VP - Bus. Development
Josh Koenig
  Josh Koenig LinkedIn Profile  Josh Koenig Twitter Account  Josh Koenig News  Josh Koenig on Facebook
VP - Bus. Development
Joep Leussink
  Joep Leussink LinkedIn Profile  Joep Leussink Twitter Account  Joep Leussink News  Joep Leussink on Facebook
VP - Customer Service
Stephen Horning
  Stephen Horning LinkedIn Profile  Stephen Horning Twitter Account  Stephen Horning News  Stephen Horning on Facebook
VP - Engineering
Sunil Bopardikar
  Sunil Bopardikar LinkedIn Profile  Sunil Bopardikar Twitter Account  Sunil Bopardikar News  Sunil Bopardikar on Facebook
VP - General Counsel
Ronak Ray
  Ronak Ray LinkedIn Profile  Ronak Ray Twitter Account  Ronak Ray News  Ronak Ray on Facebook
VP - Marketing
Karen Contos
  Karen Contos LinkedIn Profile  Karen Contos Twitter Account  Karen Contos News  Karen Contos on Facebook
VP - Product Management
Molly Presley
  Molly Presley LinkedIn Profile  Molly Presley Twitter Account  Molly Presley News  Molly Presley on Facebook
VP - Product Management
Jessica Tiwari
  Jessica Tiwari LinkedIn Profile  Jessica Tiwari Twitter Account  Jessica Tiwari News  Jessica Tiwari on Facebook
VP - Sales
Darin Wolter
  Darin Wolter LinkedIn Profile  Darin Wolter Twitter Account  Darin Wolter News  Darin Wolter on Facebook
VP - Sales
Laura Zwahlen
  Laura Zwahlen LinkedIn Profile  Laura Zwahlen Twitter Account  Laura Zwahlen News  Laura Zwahlen on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/15/2014: Sorbent Therapeutics venture capital transaction
Next: 5/15/2014: Vascular Pathways venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary